🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

68 results for “Beta” Clear

  1. A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AZD8630, Administered Once Daily via Inhalation, for 2 Weeks, in Adults with Asthma on Medium-to-high Dose Inhaled Corticosteroids and Long-acting Beta-agonists

    AstraZeneca AB

    Asthma

    phase 1 other active

    1 trial

  2. CS-101

    The First People's Hospital of Lianyungang

    Beta-Thalassemia

    phase 1 mab completed

    1 trial

  3. GMCN-508B (LentiRed)

    The First People's Hospital of Lianyungang

    Transfusion Dependent Beta-Thalassemia

    phase 1 gene therapy active

    1 trial

  4. Interferon beta-1a

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Subjects

    phase 1 mab completed

    1 trial

  5. AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , CEFEPIME , CEFOTAXIME, SPIRAMYCIN , PIPERACILLIN AND BETA-LACTAMASE INHIBITOR

    Pari Pharma GmbH

    EA-COPD (with mechanical ventilation, invasive or non-invasive, or high-flow nasal oxygen therapy).

    approved small molecule active

    1 trial

  6. AMPICILLIN , AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , OFLOXACIN , MOXIFLOXACIN , AZITHROMYCIN , LEVOFLOXACIN , AMOXICILLIN , PRISTINAMYCIN , ERYTHROMYCIN , CIPROFLOXACIN , CLARITHROMYCIN

    Pari Pharma GmbH

    Community acquired pneumonia (CAP)

    approved small molecule active

    1 trial

  7. Basiliximab,

    The First People's Hospital of Lianyungang

    Beta-Thalassemia Major

    approved small molecule completed

    1 trial

  8. Betadine bucal 100 mg/ml solución bucal, Agua oxigenada Foret 3 % solución cutánea y concentrado para solución bucal, Agua para preparaciones inyectables Meinsol, disolvente para uso parenteral

    The George Institute

    Respiratory diseases

    approved small molecule active

    1 trial

  9. Florbetapir F 18 (18F-AV-45)

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  10. MEROPENEM AND VABORBACTAM , LINEZOLID , TEDIZOLID , SULFAMETHOXAZOLE AND TRIMETHOPRIM , -, CEFTAZIDIME AND BETA-LACTAMASE INHIBITOR , -, DAPTOMYCIN , -, COLISTIN , -, METRONIDAZOLE , AMIKACIN , IMIPENEM, CILASTATIN AND RELEBACTAM

    Pari Pharma GmbH

    Pyogenic liver abscess

    approved small molecule active

    1 trial

  11. The placebo has the same composition as the investigational medicinal product alkacitrat effervescent tablet 2 g/tab (with the exception of the active substance), is manufactured by the same manufacturer (uni-pharma kleon tsetis pharmaceutical laboratory s.a) and is not sterile., ALKACITRAT Αναβράζον δισκίο 2 g/tab

    Lacuna Pharma Pty Ltd

    Functional Dyspepsia

    approved small molecule active

    1 trial

  12. epoetin beta [NeoRecormon]

    Hoffmann-La Roche

    Anemia

    approved small molecule terminated

    1 trial

  13. methoxy polyethylene glycol-epoetin beta [Mircera]

    Hoffmann-La Roche

    Anemia

    approved small molecule terminated

    2 trials

  14. Betaine

    Ultragenyx UK Limited

    Angelman Syndrome

    small molecule completed

    1 trial

  15. ET-01

    Guangzhou Virotech Pharmaceutical Co.,

    Transfusion Dependent Beta-Thalassaemia

    mab terminated

    1 trial

  16. ET-01

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Transfusion Dependent Beta-Thalassaemia

    mab completed

    1 trial

  17. Follitropin Beta;MSD

    Reproductive & Genetic Hospital of CITIC-Xiangya

    Infertility

    small molecule completed

    1 trial

  18. Inhaled corticosteriod/long-acting beta-agonist plus Montelukast

    Second Affiliated Hospital, School of Medicine, Zhejiang University

    Asthma

    small molecule active

    1 trial

  19. Interleukin-2

    The First People's Hospital of Lianyungang

    Beta Thalassemia Major

    small molecule active

    1 trial

  20. KL003 cell injection Drug Product

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Transfusion-dependent Beta-Thalassemia

    gene therapy active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources